ARCHIVES

FDA News: ODAC Recommends Taxol For KS; Votes Against 2 Other Drugs

This article is from The Cancer Letter archive.

Vol. 23 No. 26 | July 4, 1997

Download PDF Visit The Full Archive

Related Articles

Costs of Rosenberg Regimen Could Hinder cooperative Group Trials

January 3, 1986

Phase II Study Cohort Fails To Overcome Erlotinib Resistance

April 26, 2013

In Brief: Doug Ulman named CEO of Pelotonia

September 26, 2014

Breslow Reported Choice As HEW Asst. secretary

January 28, 1977

Mayo Clinic Develops New Jaw Reconstruction Method

August 25, 2006

ODAC Votes 13:0 to Recommend Perjeta for Accelerated Approval

September 13, 2013